Good MorningTech and financial stocks led today’s rally after a batch of upbeat earnings reports and analyst upgrades spurred buyers into sector ETFs. Investors cheered strong mid-year numbers from banks and software firms, while hyperscalers such as Amazon, Microsoft, and Meta reiterated hefty data-center buildout plans for 2025, fueling further interest in AI-linked names. Disney’s third-quarter profit beat and McDonald’s traffic boost from its value-focused McValue menu also lifted consumer-oriented shares, as the market looked past soft industry-wide foot traffic.
On the geopolitical front, President Trump announced a fresh 25% tariff on Indian imports of Russian oil—raising the total to 50%—and welcomed Apple’s pledge to invest an additional $100 billion in U.S. operations over four years. Brazil formally requested World Trade Organization consultations over the new tariffs, adding another layer of international friction. Despite these headwinds, solid corporate results kept equities modestly higher into the close. Featured: 1 Stock to Own by July 31st (Ad) 
|
Consumer Discretionary | |
Online casino and sports betting firm Rush Street Interactive Inc. (NYSE: RSI) has been one of the biggest surprises of the second-quarter earnings period. The company's impressive earnings report sent shares skyrocketing by nearly 22% in the span of just five days.
With major wins for both Rus... Read the Full Story |
|
From Our Partners | | OpenAI - the company behind ChatGPT - has begun filing confidential paperwork for what could be the largest IPO in American history.
But in nearly every major tech IPO of the last 15 years, day-one buyers underperformed. A small group using a lesser-known pre-IPO strategy made as much as 3,900% instead. Senior Technology Analyst Luke Lango calls it the Pre-IPO Backdoor - and it's opening again. | | Get the full story and a free ticker you can invest in today |
|
Technology | |
In the world of cloud computing, a market famously dominated by tech titans like Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Google (NASDAQ: GOOG), it’s easy to assume there is little room for smaller players. Their immense scale and sprawling service catalogs often define the conve... Read the Full Story |
|
Consumer Staples | |
Following a recent rally of 20.5%, shares of Celsius Holdings Inc. (NASDAQ: CELH) are gaining popularity again, especially as the stock reaches 90% of its 52-week high and shows enough momentum to potentially push investors toward a new peak for the year. However, there is one major speed bump sta... Read the Full Story |
|
From Our Partners | | Most AI portfolios hold the same handful of chip and software names - and completely ignore the physical layer. One perception-hardware company posted ~49% Q1 revenue growth with four partnership announcements in a single month.
A free report names seven companies building the automation, robotics, and semiconductor-test infrastructure that AI requires to move beyond the data center - including an automation giant that raised full-year guidance after quarterly sales rose ~12%. | | Click here to get your free copy of this report today |
|
Consumer Discretionary | |
The Walt Disney Company (NYSE: DIS) faces headwinds in 2025, as do most businesses, but the Q2 results reveal the enduring strength of the brand and the impact of Bob Iger’s return. While revenue headwinds persist for this entertainment company, the company continues to grow, and profitabi... Read the Full Story |
|
Business Services | |
It’s been quite the week for Blade Air Mobility Inc. (NASDAQ: BLDE). On August 4, Blade and Joby Aviation Inc. (NYSE: JOBY) announced the sale of Blade’s passenger mobility business to Joby for up to $125 million. That sent BLDE stock soaring 30%. Blade will become a pure-play medica... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Construction | |
While high dividend yields are enticing to many investors, the more relevant measurement of success of any stock is its total return. Total return includes a stock's dividend yield, as well as the change in share price. These two sources of return often work against each other; as shares fall, div... Read the Full Story |
|
Auto/Tires/Trucks | |
Rivian Automotive (NASDAQ: RIVN) is the latest high-profile electric vehicle (EV) automaker to release financial results, an event investors hoped would spark a recovery in the beaten-down stock. On August 5, Rivian shares closed at $12.15, down around 17% over the past 52 weeks.
Many Wall Stre... Read the Full Story |
|
Transportation | |
When Wall Street analysts decide to take a stance on a stock, investors often benefit from trying to reverse engineer this decision and shift in perspective. However, when the focus is on a group of stocks within the same industry, the chance to profit from these professional opinions becomes too ... Read the Full Story |
|
Retail/Wholesale | |
Mercado Libre’s (NASDAQ: MELI) shares are up nearly 300% in the last two years and have ample room to run. The business is growing and accelerating, with plenty of market left to address. Trading above 40x earnings in 2025, the stock is valued at roughly 12x its 2030 forecast, which is lik... Read the Full Story |
|
Technology | |
As one of the biggest companies in the world, chip giant Broadcom (NASDAQ: AVGO) operates in massive markets to bring in tens of billions in revenue a year. However, as Broadcom knows well, huge business opportunities breed competition. Marvell Technology (NASDAQ: MRVL) battles against Broadcom ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for the treatment of HeFH. It engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
